Global Montelukast Intermediate Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Montelukast Intermediate Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Montelukast Intermediate by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Montelukast Intermediate by Country/Region, 2017, 2022 & 2028

2.2 Montelukast Intermediate Segment by Type

2.2.1 GMP

2.2.2 Non-GMP

2.3 Montelukast Intermediate Sales by Type

2.3.1 Global Montelukast Intermediate Sales Market Share by Type (2017-2022)

2.3.2 Global Montelukast Intermediate Revenue and Market Share by Type (2017-2022)

2.3.3 Global Montelukast Intermediate Sale Price by Type (2017-2022)

2.4 Montelukast Intermediate Segment by Application

2.4.1 Asthma

2.4.2 Allergic Rhinitis

2.4.3 Bronchospasm

2.4.4 Urticaria

2.5 Montelukast Intermediate Sales by Application

2.5.1 Global Montelukast Intermediate Sale Market Share by Application (2017-2022)

2.5.2 Global Montelukast Intermediate Revenue and Market Share by Application (2017-2022)

2.5.3 Global Montelukast Intermediate Sale Price by Application (2017-2022)

3 Global Montelukast Intermediate by Company

3.1 Global Montelukast Intermediate Breakdown Data by Company

3.1.1 Global Montelukast Intermediate Annual Sales by Company (2020-2022)

3.1.2 Global Montelukast Intermediate Sales Market Share by Company (2020-2022)

3.2 Global Montelukast Intermediate Annual Revenue by Company (2020-2022)

3.2.1 Global Montelukast Intermediate Revenue by Company (2020-2022)

3.2.2 Global Montelukast Intermediate Revenue Market Share by Company (2020-2022)

3.3 Global Montelukast Intermediate Sale Price by Company

3.4 Key Manufacturers Montelukast Intermediate Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Montelukast Intermediate Product Location Distribution

3.4.2 Players Montelukast Intermediate Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Montelukast Intermediate by Geographic Region

4.1 World Historic Montelukast Intermediate Market Size by Geographic Region (2017-2022)

4.1.1 Global Montelukast Intermediate Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Montelukast Intermediate Annual Revenue by Geographic Region

4.2 World Historic Montelukast Intermediate Market Size by Country/Region (2017-2022)

4.2.1 Global Montelukast Intermediate Annual Sales by Country/Region (2017-2022)

4.2.2 Global Montelukast Intermediate Annual Revenue by Country/Region

4.3 Americas Montelukast Intermediate Sales Growth

4.4 APAC Montelukast Intermediate Sales Growth

4.5 Europe Montelukast Intermediate Sales Growth

4.6 Middle East & Africa Montelukast Intermediate Sales Growth

5 Americas

5.1 Americas Montelukast Intermediate Sales by Country

5.1.1 Americas Montelukast Intermediate Sales by Country (2017-2022)

5.1.2 Americas Montelukast Intermediate Revenue by Country (2017-2022)

5.2 Americas Montelukast Intermediate Sales by Type

5.3 Americas Montelukast Intermediate Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Montelukast Intermediate Sales by Region

6.1.1 APAC Montelukast Intermediate Sales by Region (2017-2022)

6.1.2 APAC Montelukast Intermediate Revenue by Region (2017-2022)

6.2 APAC Montelukast Intermediate Sales by Type

6.3 APAC Montelukast Intermediate Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Montelukast Intermediate by Country

7.1.1 Europe Montelukast Intermediate Sales by Country (2017-2022)

7.1.2 Europe Montelukast Intermediate Revenue by Country (2017-2022)

7.2 Europe Montelukast Intermediate Sales by Type

7.3 Europe Montelukast Intermediate Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Montelukast Intermediate by Country

8.1.1 Middle East & Africa Montelukast Intermediate Sales by Country (2017-2022)

8.1.2 Middle East & Africa Montelukast Intermediate Revenue by Country (2017-2022)

8.2 Middle East & Africa Montelukast Intermediate Sales by Type

8.3 Middle East & Africa Montelukast Intermediate Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Montelukast Intermediate

10.3 Manufacturing Process Analysis of Montelukast Intermediate

10.4 Industry Chain Structure of Montelukast Intermediate

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Montelukast Intermediate Distributors

11.3 Montelukast Intermediate Customer

12 World Forecast Review for Montelukast Intermediate by Geographic Region

12.1 Global Montelukast Intermediate Market Size Forecast by Region

12.1.1 Global Montelukast Intermediate Forecast by Region (2023-2028)

12.1.2 Global Montelukast Intermediate Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Montelukast Intermediate Forecast by Type

12.7 Global Montelukast Intermediate Forecast by Application

13 Key Players Analysis

13.1 VIVAN Life Sciences

13.1.1 VIVAN Life Sciences Company Information

13.1.2 VIVAN Life Sciences Montelukast Intermediate Product Offered

13.1.3 VIVAN Life Sciences Montelukast Intermediate Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 VIVAN Life Sciences Main Business Overview

13.1.5 VIVAN Life Sciences Latest Developments

13.2 P.G. Shah & Co.

13.2.1 P.G. Shah & Co. Company Information

13.2.2 P.G. Shah & Co. Montelukast Intermediate Product Offered

13.2.3 P.G. Shah & Co. Montelukast Intermediate Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 P.G. Shah & Co. Main Business Overview

13.2.5 P.G. Shah & Co. Latest Developments

13.3 Manus Aktteva Biopharma

13.3.1 Manus Aktteva Biopharma Company Information

13.3.2 Manus Aktteva Biopharma Montelukast Intermediate Product Offered

13.3.3 Manus Aktteva Biopharma Montelukast Intermediate Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Manus Aktteva Biopharma Main Business Overview

13.3.5 Manus Aktteva Biopharma Latest Developments

13.4 Ortin Laboratories

13.4.1 Ortin Laboratories Company Information

13.4.2 Ortin Laboratories Montelukast Intermediate Product Offered

13.4.3 Ortin Laboratories Montelukast Intermediate Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Ortin Laboratories Main Business Overview

13.4.5 Ortin Laboratories Latest Developments

14 Research Findings and Conclusion

Table 1. Montelukast Intermediate Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Montelukast Intermediate Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of GMP

Table 4. Major Players of Non-GMP

Table 5. Global Montelukast Intermediate Sales by Type (2017-2022) & (MT)

Table 6. Global Montelukast Intermediate Sales Market Share by Type (2017-2022)

Table 7. Global Montelukast Intermediate Revenue by Type (2017-2022) & ($ million)

Table 8. Global Montelukast Intermediate Revenue Market Share by Type (2017-2022)

Table 9. Global Montelukast Intermediate Sale Price by Type (2017-2022) & (USD/MT)

Table 10. Global Montelukast Intermediate Sales by Application (2017-2022) & (MT)

Table 11. Global Montelukast Intermediate Sales Market Share by Application (2017-2022)

Table 12. Global Montelukast Intermediate Revenue by Application (2017-2022)

Table 13. Global Montelukast Intermediate Revenue Market Share by Application (2017-2022)

Table 14. Global Montelukast Intermediate Sale Price by Application (2017-2022) & (USD/MT)

Table 15. Global Montelukast Intermediate Sales by Company (2020-2022) & (MT)

Table 16. Global Montelukast Intermediate Sales Market Share by Company (2020-2022)

Table 17. Global Montelukast Intermediate Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Montelukast Intermediate Revenue Market Share by Company (2020-2022)

Table 19. Global Montelukast Intermediate Sale Price by Company (2020-2022) & (USD/MT)

Table 20. Key Manufacturers Montelukast Intermediate Producing Area Distribution and Sales Area

Table 21. Players Montelukast Intermediate Products Offered

Table 22. Montelukast Intermediate Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Montelukast Intermediate Sales by Geographic Region (2017-2022) & (MT)

Table 26. Global Montelukast Intermediate Sales Market Share Geographic Region (2017-2022)

Table 27. Global Montelukast Intermediate Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Montelukast Intermediate Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Montelukast Intermediate Sales by Country/Region (2017-2022) & (MT)

Table 30. Global Montelukast Intermediate Sales Market Share by Country/Region (2017-2022)

Table 31. Global Montelukast Intermediate Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Montelukast Intermediate Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Montelukast Intermediate Sales by Country (2017-2022) & (MT)

Table 34. Americas Montelukast Intermediate Sales Market Share by Country (2017-2022)

Table 35. Americas Montelukast Intermediate Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Montelukast Intermediate Revenue Market Share by Country (2017-2022)

Table 37. Americas Montelukast Intermediate Sales by Type (2017-2022) & (MT)

Table 38. Americas Montelukast Intermediate Sales Market Share by Type (2017-2022)

Table 39. Americas Montelukast Intermediate Sales by Application (2017-2022) & (MT)

Table 40. Americas Montelukast Intermediate Sales Market Share by Application (2017-2022)

Table 41. APAC Montelukast Intermediate Sales by Region (2017-2022) & (MT)

Table 42. APAC Montelukast Intermediate Sales Market Share by Region (2017-2022)

Table 43. APAC Montelukast Intermediate Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Montelukast Intermediate Revenue Market Share by Region (2017-2022)

Table 45. APAC Montelukast Intermediate Sales by Type (2017-2022) & (MT)

Table 46. APAC Montelukast Intermediate Sales Market Share by Type (2017-2022)

Table 47. APAC Montelukast Intermediate Sales by Application (2017-2022) & (MT)

Table 48. APAC Montelukast Intermediate Sales Market Share by Application (2017-2022)

Table 49. Europe Montelukast Intermediate Sales by Country (2017-2022) & (MT)

Table 50. Europe Montelukast Intermediate Sales Market Share by Country (2017-2022)

Table 51. Europe Montelukast Intermediate Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Montelukast Intermediate Revenue Market Share by Country (2017-2022)

Table 53. Europe Montelukast Intermediate Sales by Type (2017-2022) & (MT)

Table 54. Europe Montelukast Intermediate Sales Market Share by Type (2017-2022)

Table 55. Europe Montelukast Intermediate Sales by Application (2017-2022) & (MT)

Table 56. Europe Montelukast Intermediate Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Montelukast Intermediate Sales by Country (2017-2022) & (MT)

Table 58. Middle East & Africa Montelukast Intermediate Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Montelukast Intermediate Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Montelukast Intermediate Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Montelukast Intermediate Sales by Type (2017-2022) & (MT)

Table 62. Middle East & Africa Montelukast Intermediate Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Montelukast Intermediate Sales by Application (2017-2022) & (MT)

Table 64. Middle East & Africa Montelukast Intermediate Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Montelukast Intermediate

Table 66. Key Market Challenges & Risks of Montelukast Intermediate

Table 67. Key Industry Trends of Montelukast Intermediate

Table 68. Montelukast Intermediate Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Montelukast Intermediate Distributors List

Table 71. Montelukast Intermediate Customer List

Table 72. Global Montelukast Intermediate Sales Forecast by Region (2023-2028) & (MT)

Table 73. Global Montelukast Intermediate Sales Market Forecast by Region

Table 74. Global Montelukast Intermediate Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Montelukast Intermediate Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Montelukast Intermediate Sales Forecast by Country (2023-2028) & (MT)

Table 77. Americas Montelukast Intermediate Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Montelukast Intermediate Sales Forecast by Region (2023-2028) & (MT)

Table 79. APAC Montelukast Intermediate Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Montelukast Intermediate Sales Forecast by Country (2023-2028) & (MT)

Table 81. Europe Montelukast Intermediate Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Montelukast Intermediate Sales Forecast by Country (2023-2028) & (MT)

Table 83. Middle East & Africa Montelukast Intermediate Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Montelukast Intermediate Sales Forecast by Type (2023-2028) & (MT)

Table 85. Global Montelukast Intermediate Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Montelukast Intermediate Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Montelukast Intermediate Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Montelukast Intermediate Sales Forecast by Application (2023-2028) & (MT)

Table 89. Global Montelukast Intermediate Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Montelukast Intermediate Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Montelukast Intermediate Revenue Market Share Forecast by Application (2023-2028)

Table 92. VIVAN Life Sciences Basic Information, Montelukast Intermediate Manufacturing Base, Sales Area and Its Competitors

Table 93. VIVAN Life Sciences Montelukast Intermediate Product Offered

Table 94. VIVAN Life Sciences Montelukast Intermediate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 95. VIVAN Life Sciences Main Business

Table 96. VIVAN Life Sciences Latest Developments

Table 97. P.G. Shah & Co. Basic Information, Montelukast Intermediate Manufacturing Base, Sales Area and Its Competitors

Table 98. P.G. Shah & Co. Montelukast Intermediate Product Offered

Table 99. P.G. Shah & Co. Montelukast Intermediate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 100. P.G. Shah & Co. Main Business

Table 101. P.G. Shah & Co. Latest Developments

Table 102. Manus Aktteva Biopharma Basic Information, Montelukast Intermediate Manufacturing Base, Sales Area and Its Competitors

Table 103. Manus Aktteva Biopharma Montelukast Intermediate Product Offered

Table 104. Manus Aktteva Biopharma Montelukast Intermediate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 105. Manus Aktteva Biopharma Main Business

Table 106. Manus Aktteva Biopharma Latest Developments

Table 107. Ortin Laboratories Basic Information, Montelukast Intermediate Manufacturing Base, Sales Area and Its Competitors

Table 108. Ortin Laboratories Montelukast Intermediate Product Offered

Table 109. Ortin Laboratories Montelukast Intermediate Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 110. Ortin Laboratories Main Business

Table 111. Ortin Laboratories Latest Developments

List of Figures

Figure 1. Picture of Montelukast Intermediate

Figure 2. Montelukast Intermediate Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Montelukast Intermediate Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Montelukast Intermediate Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Montelukast Intermediate Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of GMP

Figure 10. Product Picture of Non-GMP

Figure 11. Global Montelukast Intermediate Sales Market Share by Type in 2021

Figure 12. Global Montelukast Intermediate Revenue Market Share by Type (2017-2022)

Figure 13. Montelukast Intermediate Consumed in Asthma

Figure 14. Global Montelukast Intermediate Market: Asthma (2017-2022) & (MT)

Figure 15. Montelukast Intermediate Consumed in Allergic Rhinitis

Figure 16. Global Montelukast Intermediate Market: Allergic Rhinitis (2017-2022) & (MT)

Figure 17. Montelukast Intermediate Consumed in Bronchospasm

Figure 18. Global Montelukast Intermediate Market: Bronchospasm (2017-2022) & (MT)

Figure 19. Montelukast Intermediate Consumed in Urticaria

Figure 20. Global Montelukast Intermediate Market: Urticaria (2017-2022) & (MT)

Figure 21. Global Montelukast Intermediate Sales Market Share by Application (2017-2022)

Figure 22. Global Montelukast Intermediate Revenue Market Share by Application in 2021

Figure 23. Montelukast Intermediate Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Montelukast Intermediate Revenue Market Share by Company in 2021

Figure 25. Global Montelukast Intermediate Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Montelukast Intermediate Revenue Market Share by Geographic Region in 2021

Figure 27. Global Montelukast Intermediate Sales Market Share by Region (2017-2022)

Figure 28. Global Montelukast Intermediate Revenue Market Share by Country/Region in 2021

Figure 29. Americas Montelukast Intermediate Sales 2017-2022 (MT)

Figure 30. Americas Montelukast Intermediate Revenue 2017-2022 ($ Millions)

Figure 31. APAC Montelukast Intermediate Sales 2017-2022 (MT)

Figure 32. APAC Montelukast Intermediate Revenue 2017-2022 ($ Millions)

Figure 33. Europe Montelukast Intermediate Sales 2017-2022 (MT)

Figure 34. Europe Montelukast Intermediate Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Montelukast Intermediate Sales 2017-2022 (MT)

Figure 36. Middle East & Africa Montelukast Intermediate Revenue 2017-2022 ($ Millions)

Figure 37. Americas Montelukast Intermediate Sales Market Share by Country in 2021

Figure 38. Americas Montelukast Intermediate Revenue Market Share by Country in 2021

Figure 39. United States Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Montelukast Intermediate Sales Market Share by Region in 2021

Figure 44. APAC Montelukast Intermediate Revenue Market Share by Regions in 2021

Figure 45. China Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Montelukast Intermediate Sales Market Share by Country in 2021

Figure 52. Europe Montelukast Intermediate Revenue Market Share by Country in 2021

Figure 53. Germany Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Montelukast Intermediate Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Montelukast Intermediate Revenue Market Share by Country in 2021

Figure 60. Egypt Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Montelukast Intermediate Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Montelukast Intermediate in 2021

Figure 66. Manufacturing Process Analysis of Montelukast Intermediate

Figure 67. Industry Chain Structure of Montelukast Intermediate

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles